Expression of the putative cannabinoid receptor GPR55 is increased in endometrial carcinoma
Open Access
- 29 July 2021
- journal article
- research article
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 156 (5) , 449-460
Abstract
Although the expression of the putative cannabinoid receptor GPR55 has been shown to be involved in the growth of various tumours and is increased in a number of cancers, its expression has not been examined in patients with endometrial cancer (EC). Quantitative RT-PCR (for mRNA levels) and immunohistochemistry (for protein levels) were used to measure GPR55 expression in patients with Type 1 and Type 2 EC and correlated against cannabinoid receptor (CB1 and CB2) protein levels using non-cancerous endometrium as the control tissue. The data indicated that GPR55 transcript and GPR55 protein levels were significantly (p < 0.002 and p < 0.0001, respectively) higher in EC tissues than in control tissues. The levels of immunoreactive GPR55 protein were correlated with GPR55 transcript levels, but not with the expression of CB1 receptor protein, and were inversely correlated with CB2 protein expression, which was significantly decreased. It can be concluded that GPR55 expression is elevated in women with EC, and thus could provide a potential novel biomarker and therapeutic target for this disease.Keywords
This publication has 65 references indexed in Scilit:
- Orphan G protein receptor GPR55 as an emerging target in cancer therapy and managementCancer Management and Research, 2013
- p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humansEMBO Molecular Medicine, 2012
- Obesity-Dependent Metabolic Signatures Associated with Nonalcoholic Fatty Liver Disease ProgressionJournal of Proteome Research, 2012
- Thel-α-Lysophosphatidylinositol/GPR55System and Its Potential Role in Human ObesityDiabetes, 2012
- A role for L‐α‐lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cellsBritish Journal of Pharmacology, 2010
- GPR55 ligands promote receptor coupling to multiple signalling pathwaysBritish Journal of Pharmacology, 2010
- The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivoProceedings of the National Academy of Sciences, 2009
- The orphan receptor GPR55 is a novel cannabinoid receptorBritish Journal of Pharmacology, 2007
- Identification of GPR55 as a lysophosphatidylinositol receptorBiochemical and Biophysical Research Communications, 2007
- Novel cannabinoid receptorsBritish Journal of Pharmacology, 2007